Pete Chan

Pete Chan has a diverse background in health tech, pharma/biotech, and patient-driven solutions. Currently serving as a Director at Mellifluo Trends, Pete also holds positions as an External Expert at admedicum, Board Trustee at Orchard OCD, Working Group Member & Advisor at Rare Disease Research Network, and Advisor at Sireau Labs. With experience in writing and research roles at various companies including A Life in a Day, Future Science Group, and Ayzee, Pete brings a wealth of knowledge to the field. Additionally, as the former Head of Research & Analysis and Chief Innovation Advocate at Xperiome, Pete has extensive experience in rare disease patient insights and clinical trial recruitment.